XML 32 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Disclosures (Tables)
12 Months Ended
Nov. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule Of Assets And Liabilities Measured On Recurring Basis At Fair Value
The following is a summary of our financial instruments, securities purchased under agreements to resell, securities received as collateral, trading liabilities, long-term debt and obligation to return securities received as collateral that are accounted for at fair value on a recurring basis, excluding Investments at fair value based on net asset value ("NAV") (within trading assets) of $586.9 million and $394.4 million at November 30, 2019 and 2018, respectively, by level within the fair value hierarchy (in thousands):
 
November 30, 2019
 
Level 1
 
Level 2
 
Level 3
 
Counterparty
and
Cash
Collateral
Netting (1)
 
Total
Assets:
 
 
 
 
 
 
 
 
 
Trading assets, at fair value:
 
 
 
 
 
 
 
 
 
Corporate equity securities
$
2,507,164

 
$
218,403

 
$
58,426

 
$

 
$
2,783,993

Corporate debt securities

 
2,472,245

 
7,490

 

 
2,479,735

Collateralized debt obligations and
collateralized loan obligations

 
124,225

 
28,788

 

 
153,013

U.S. government and federal agency securities
2,101,624

 
158,618

 

 

 
2,260,242

Municipal securities

 
742,326

 

 

 
742,326

Sovereign obligations
1,330,026

 
1,405,827

 

 

 
2,735,853

Residential mortgage-backed securities

 
1,069,066

 
17,740

 

 
1,086,806

Commercial mortgage-backed securities

 
424,060

 
6,110

 

 
430,170

Other asset-backed securities

 
303,847

 
42,563

 

 
346,410

Loans and other receivables

 
2,460,551

 
114,080

 

 
2,574,631

Derivatives
2,809

 
1,833,907

 
14,889

 
(1,433,197
)
 
418,408

Investments at fair value

 
32,688

 
205,412

 

 
238,100

FXCM term loan

 

 
59,120

 

 
59,120

Total trading assets, excluding investments at fair value based on NAV
$
5,941,623

 
$
11,245,763

 
$
554,618

 
$
(1,433,197
)
 
$
16,308,807

Securities purchased under agreements to resell
$

 
$

 
$
25,000

 
$

 
$
25,000

Securities received as collateral
$
9,500

 
$

 
$

 
$

 
$
9,500

 
 
 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

 
 

Trading liabilities:
 

 
 

 
 

 
 

 
 

Corporate equity securities
$
2,755,601

 
$
7,438

 
$
4,487

 
$

 
$
2,767,526

Corporate debt securities

 
1,471,142

 
340

 

 
1,471,482

U.S. government and federal agency securities
1,851,981

 

 

 

 
1,851,981

Sovereign obligations
1,363,475

 
941,065

 

 

 
2,304,540

Commercial mortgage-backed securities

 

 
35

 

 
35

Loans

 
1,600,228

 
9,463

 

 
1,609,691

Derivatives
871

 
2,066,455

 
92,057

 
(1,632,178
)
 
527,205

Total trading liabilities
$
5,971,928

 
$
6,086,328

 
$
106,382

 
$
(1,632,178
)
 
$
10,532,460

Short-term borrowings
$

 
$
20,981

 
$

 
$

 
$
20,981

Long-term debt
$

 
$
735,216

 
$
480,069

 
$

 
$
1,215,285

Obligation to return securities received as collateral
$
9,500

 
$

 
$

 
$

 
$
9,500

 
November 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Counterparty
and
Cash
Collateral
Netting (1)
 
Total
Assets:
 
 
 
 
 
 
 
 
 
Trading assets, at fair value:
 
 
 
 
 
 
 
 
 
Corporate equity securities
$
2,497,045

 
$
118,681

 
$
52,192

 
$

 
$
2,667,918

Corporate debt securities

 
2,683,180

 
9,484

 

 
2,692,664

Collateralized debt obligations and
collateralized loan obligations

 
72,949

 
36,105

 

 
109,054

U.S. government and federal agency securities
1,789,614

 
56,592

 

 

 
1,846,206

Municipal securities

 
894,253

 

 

 
894,253

Sovereign obligations
1,769,556

 
1,043,409

 

 

 
2,812,965

Residential mortgage-backed securities

 
2,163,629

 
19,603

 

 
2,183,232

Commercial mortgage-backed securities

 
819,406

 
10,886

 

 
830,292

Other asset-backed securities

 
239,381

 
53,175

 

 
292,556

Loans and other receivables

 
2,056,593

 
46,985

 

 
2,103,578

Derivatives
34,841

 
2,539,943

 
5,922

 
(2,413,931
)
 
166,775

Investments at fair value

 

 
396,254

 

 
396,254

FXCM term loan

 

 
73,150

 

 
73,150

Total trading assets, excluding investments at fair value based on NAV
$
6,091,056

 
$
12,688,016

 
$
703,756

 
$
(2,413,931
)
 
$
17,068,897

 
 
 
 
 
 
 
 
 
 
Available for sale securities:
 

 
 

 
 

 
 

 
 

U.S. government securities
$
1,072,856

 
$

 
$

 
$

 
$
1,072,856

Residential mortgage-backed securities

 
210,518

 

 

 
210,518

Commercial mortgage-backed securities

 
15,642

 

 

 
15,642

Other asset-backed securities

 
110,870

 

 

 
110,870

Total available for sale securities
$
1,072,856

 
$
337,030

 
$

 
$

 
$
1,409,886

 
 
 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

 
 

Trading liabilities:
 

 
 

 
 

 
 

 
 

Corporate equity securities
$
1,685,071

 
$
1,444

 
$

 
$

 
$
1,686,515

Corporate debt securities

 
1,505,618

 
522

 

 
1,506,140

U.S. government and federal agency securities
1,384,295

 

 

 

 
1,384,295

Sovereign obligations
1,735,242

 
661,095

 

 

 
2,396,337

Loans

 
1,371,630

 
6,376

 

 
1,378,006

Derivatives
26,473

 
3,586,694

 
27,536

 
(2,513,050
)
 
1,127,653

Total trading liabilities
$
4,831,081

 
$
7,126,481

 
$
34,434

 
$
(2,513,050
)
 
$
9,478,946

Long-term debt
$

 
$
485,425

 
$
200,745

 
$

 
$
686,170

(1)
Represents counterparty and cash collateral netting across the levels of the fair value hierarchy for positions with the same counterparty.
Investments Measured At Fair Value Based On Net Asset Value
The following tables present information about our investments in entities that have the characteristics of an investment company (in thousands).
 
Fair Value (1)
 
Unfunded
Commitments
November 30, 2019
 
 
 
Equity Long/Short Hedge Funds (2)
$
291,593

 
$

Equity Funds (3)
44,576

 
14,621

Commodity Fund (4)
16,025

 

Multi-asset Funds (5)
234,583

 

Other Funds (6)
157

 

Total
$
586,934

 
$
14,621

 
 
 
 
November 30, 2018
 
 
 
Equity Long/Short Hedge Funds (2)
$
86,788

 
$

Equity Funds (3)
40,070

 
20,996

Commodity Fund (4)
10,129

 

Multi-asset Funds (5)
256,972

 

Other Funds (6)
400

 

Total
$
394,359

 
$
20,996

(1)
Where fair value is calculated based on NAV, fair value has been derived from each of the funds' capital statements.
(2)
This category includes investments in hedge funds that invest, long and short, primarily in equity securities in domestic and international markets in both the public and private sectors. At November 30, 2019 and 2018, approximately 94% and 0%, respectively, of the fair value of investments in this category cannot be redeemed because these investments include restrictions that do not allow for redemption in the first 36 months after acquisition. At November 30, 2019 and 2018, 6% and 17%, respectively, of these investments are redeemable with 60 days prior written notice. Approximately 82% of the November 30, 2018 balance was redeemed during the twelve months ended November 30, 2019.
(3)
The investments in this category include investments in equity funds that invest in the equity of various U.S. and foreign private companies. These investments cannot be redeemed; instead distributions are received through the liquidation of the underlying assets of the funds, which are expected to liquidate in one to nine years
(4)
This category includes investments in a hedge fund that invests, long and short, primarily in commodities. Investments in this category are redeemable quarterly with 60 days prior written notice.
(5)
This category includes investments in hedge funds that invest, long and short, primarily in multi-asset securities in domestic and international markets in both the public and private sectors. At November 30, 2019 and 2018, investments representing approximately 5% and 15%, respectively, of the fair value of investments in this category are redeemable with 30 days prior written notice.
(6)
This category includes investments in a fund that invests in loans secured by a first trust deed on property, domestic and international public high yield debt, private high yield investments, senior bank loans, public leveraged equities, distressed debt and private equity investments and there are no redemption provisions. This category also includes investments in a fund of funds that invests in various private equity funds that are managed by Jefferies Group and have no redemption provisions. Investments in the fund of funds are gradually being liquidated, however, the timing of when the proceeds will be received is uncertain.
Summary Of Changes In Fair Value Of Financial Assets And Liabilities Classified As Level 3
The following is a summary of changes in fair value of our financial assets and liabilities that have been categorized within Level 3 of the fair value hierarchy for the eleven months ended November 30, 2018 (in thousands):
Eleven Months Ended November 30, 2018
 
Balance, December 31, 2017
 
Total gains (losses)
(realized and unrealized) (1)
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Net transfers
into (out of)
Level 3
 
Balance, November 30, 2018
 
Changes in
unrealized gains (losses) relating to instruments still held at
November 30, 2018 (1)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate equity securities
$
22,270

 
$
24,914

 
$
31,669

 
$
(22,759
)
 
$
(3,977
)
 
$

 
$
75

 
$
52,192

 
$
23,665

Corporate debt securities
26,036

 
(439
)
 
10,352

 
(23,364
)
 
(1,679
)
 

 
(1,422
)
 
9,484

 
(2,606
)
CDOs and CLOS
42,184

 
(16,258
)
 
356,650

 
(353,330
)
 
(10,247
)
 

 
17,106

 
36,105

 
(9,495
)
Residential mortgage- backed securities
26,077

 
(6,970
)
 
3,118

 
(12,816
)
 
(513
)
 

 
10,707

 
19,603

 
521

Commercial mortgage-backed securities
12,419

 
(2,186
)
 
1,436

 
(471
)
 
(16,624
)
 

 
16,312

 
10,886

 
(4,000
)
Other asset-backed securities
61,129

 
(9,934
)
 
706,846

 
(677,220
)
 
(27,641
)
 

 
(5
)
 
53,175

 
(5,283
)
Loans and other receivables
47,304

 
(5,137
)
 
149,228

 
(130,832
)
 
(15,311
)
 

 
1,733

 
46,985

 
(8,457
)
Investments at fair value
329,944

 
76,636

 
9,798

 
(17,570
)
 

 

 
(2,554
)
 
396,254

 
76,042

Investment in FXCM
72,800

 
18,616

 

 

 
(18,266
)
 

 

 
73,150

 
7,723

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
Trading liabilities:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Corporate equity securities
$
48

 
$

 
$

 
$

 
$

 
$

 
$
(48
)
 
$

 
$

Corporate debt securities
522

 

 

 

 

 

 

 
522

 

Commercial mortgage-backed securities
105

 
(105
)
 

 

 

 

 

 

 

Loans
3,486

 
84

 
(4,626
)
 
7,432

 

 

 

 
6,376

 
(28
)
Net derivatives (2)
6,746

 
(3,237
)
 
(17
)
 
14,920

 
(1,335
)
 

 
4,537

 
21,614

 
(646
)
Long-term debt (1)

 
(30,347
)
 

 

 

 
84,860

 
146,232

 
200,745

 
10,951


(1)
Realized and unrealized gains (losses) are primarily reported in Principal transactions revenues in the Consolidated Statements of Operations. Changes in instrument-specific credit risk related to structured notes are included in the Consolidated Statements of Comprehensive Income (Loss), net of tax. Changes in unrealized gains (losses) included in other comprehensive income (loss) for instruments still held at November 30, 2018 were gains of $19.4 million.
(2)
Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives.
The following is a summary of changes in fair value of our financial assets and liabilities that have been categorized within Level 3 of the fair value hierarchy for the twelve months ended November 30, 2019 (in thousands):
Twelve Months Ended November 30, 2019
 
Balance, November 30, 2018
 
Total gains (losses)
(realized and unrealized) (1)
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Net transfers
into (out of)
Level 3
 
Balance, November 30, 2019
 
Changes in
unrealized gains/losses included in earnings relating to instruments still held at
November 30, 2019 (1)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate equity securities
$
52,192

 
$
(11,407
)
 
$
69,065

 
$
(28,159
)
 
$
(18,208
)
 
$

 
$
(5,057
)
 
$
58,426

 
$
(13,848
)
Corporate debt securities
9,484

 
(4,860
)
 
8,900

 
(13,854
)
 
(379
)
 

 
8,199

 
7,490

 
(6,176
)
CDOs and CLOs
36,105

 
(514
)
 
49,658

 
(38,147
)
 
(12,494
)
 

 
(5,820
)
 
28,788

 
(2,330
)
Residential mortgage-backed securities
19,603

 
(1,669
)
 
1,954

 
(2,472
)
 
(152
)
 

 
476

 
17,740

 
(530
)
Commercial mortgage-backed securities
10,886

 
(2,888
)
 
206

 
(2,346
)
 
(5,317
)
 

 
5,569

 
6,110

 
(2,366
)
Other asset-backed securities
53,175

 
433

 
104,097

 
(73,335
)
 
(51,374
)
 

 
9,567

 
42,563

 
(98
)
Loans and other receivables
46,985

 
(4,507
)
 
106,965

 
(48,350
)
 
(5,788
)
 

 
18,775

 
114,080

 
(2,321
)
Investments at fair value
396,254

 
(183,480
)
 
11,236

 
(28,749
)
 

 

 
10,151

 
205,412

 
(180,629
)
Investment in FXCM
73,150

 
(8,139
)
 
1,500

 

 
(7,391
)
 

 

 
59,120

 
(8,139
)
Securities purchased under agreements to resell

 

 

 

 

 
25,000

 

 
25,000

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading liabilities:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Corporate equity securities
$

 
$
(2,649
)
 
$
(4,322
)
 
$
11,458

 
$

 
$

 
$

 
$
4,487

 
$
1,928

Corporate debt securities
522

 
(381
)
 
(457
)
 

 
(524
)
 

 
1,180

 
340

 
383

Commercial mortgage-backed securities

 
35

 

 

 

 

 

 
35

 
35

Loans
6,376

 
(1,382
)
 
(2,573
)
 
6,494

 

 

 
548

 
9,463

 
1,382

Net derivatives (2)
21,614

 
(21,452
)
 
(4,323
)
 
36,144

 
2,227

 

 
42,958

 
77,168

 
12,098

Long-term debt (1)
200,745

 
(18,662
)
 

 

 
(11,250
)
 
348,275

 
(39,039
)
 
480,069

 
29,656


(1)
Realized and unrealized gains (losses) are primarily reported in Principal transactions revenues in the Consolidated Statements of Operations. Changes in instrument-specific credit risk related to structured notes are included in the Consolidated Statements of Comprehensive Income (Loss), net of tax. Changes in unrealized gains (losses) included in other comprehensive income (loss) for instruments still held at November 30, 2019 were losses of $11.0 million.
(2)
Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives.
Twelve Months Ended December 31, 2017
 
Balance, December 31, 2016
 
Total gains (losses)
(realized and unrealized) (1)
 
Purchases
 
Sales
 
Settlements
 
Issuances
 
Net transfers
into (out of)
Level 3
 
Balance, December 31, 2017
 
Changes in
unrealized gains (losses) relating to instruments still held at
December 31, 2017 (1)
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trading assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate equity securities
$
21,739

 
$
3,353

 
$
896

 
$
(1,623
)
 
$
52

 
$

 
$
(2,147
)
 
$
22,270

 
$
2,606

Corporate debt securities
25,005

 
(3,723
)
 
36,850

 
(34,077
)
 
(1,968
)
 

 
3,949

 
26,036

 
(3,768
)
CDOs and CLOs
54,354

 
(27,238
)
 
112,239

 
(101,226
)
 
(367
)
 

 
4,422

 
42,184

 
(20,262
)
Municipal securities
27,257

 
(1,547
)
 

 
(25,710
)
 

 

 

 

 

Residential mortgage-backed securities
38,772

 
(10,817
)
 
6,805

 
(26,193
)
 
(115
)
 

 
17,625

 
26,077

 
(7,201
)
Commercial mortgage-backed securities
20,580

 
(5,346
)
 
3,275

 
(5,263
)
 
(1,018
)
 

 
191

 
12,419

 
(6,976
)
Other asset-backed securities
40,911

 
(17,705
)
 
77,508

 
(8,613
)
 
(25,799
)
 

 
(5,173
)
 
61,129

 
(12,562
)
Loans and other receivables
81,872

 
24,794

 
63,768

 
(53,095
)
 
(34,622
)
 

 
(35,413
)
 
47,304

 
17,451

Investments at fair value
314,359

 
20,975

 
18,528

 
(22,818
)
 
(1,100
)
 

 

 
329,944

 
22,999

Investment in FXCM
164,500

 
23,161

 

 

 
(114,861
)
 

 

 
72,800

 
1,070

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 

 
 

 
 

 
 

 
 

 
 
 
 

 
 

 
 

Trading liabilities:
 

 
 

 
 

 
 

 
 

 
 
 
 

 
 

 
 

Corporate equity securities
$
313

 
$
60

 
$
(373
)
 
$
48

 
$

 
$

 
$

 
$
48

 
$

Corporate debt securities
523

 
(1
)
 

 

 

 

 

 
522

 
1

Commercial mortgage-backed securities

 
105

 

 

 

 

 

 
105

 
(105
)
Loans
378

 
196

 
(385
)
 
2,485

 

 

 
812

 
3,486

 
(2,639
)
Net derivatives (2)
3,441

 
(1,638
)
 

 

 
5,558

 
456

 
(1,071
)
 
6,746

 
(17,740
)
Other secured financings
418

 
(418
)
 

 

 

 

 

 

 


(1)
Realized and unrealized gains (losses) are reported in Principal transactions revenues in the Consolidated Statements of Operations.
(2)
Net derivatives represent Trading assets - Derivatives and Trading liabilities - Derivatives.
Quantitative Information About Significant Unobservable Inputs Used In Level 3 Fair Value Measurements

November 30, 2019
Financial Instruments Owned
 
Fair Value
(in thousands)
 
Valuation
 Technique
 
Significant
Unobservable Input(s)
 
Input/Range
 
Weighted
Average
Corporate equity securities
 
$
29,017

 
 
 
 
 
 
 
 
 
 
Non-exchange traded securities
 
 

 
Market approach
 
Price
 
$1
to
$140
 
$55
 
 
 
 
 
 
Underlying stock price
 
$3
to
$5
 
$4
 
 
 
 
 
 
 
 
 
 
 
Corporate debt securities
 
$
7,490

 
Scenario analysis
 
Estimated recovery percentage
 
23
%
to
85%
 
46
%
 
 
 
 
 
 
Volatility
 
44%
 

 
 
 
 
 
 
Credit spread
 
750
 

 
 
 
 
 
 
Underlying stock price
 
£0.4
 

 
 
 
 
 
 
 
 
 
 
 
CDOs and CLOs
 
$
28,788

 
Discounted cash flows
 
Constant prepayment rate
 
20%
 

 
 
 

 
   
 
Constant default rate
 
1
%
to
2%
 
2
%
 
 
 

 
   
 
Loss severity
 
25
%
to
37%
 
29
%
 
 
 

 
   
 
Discount rate/yield
 
12
%
to
21%
 
15
%
 
 
 
 
Scenario analysis
 
Estimated recovery percentage
 
3.25
%
to
36.5%
 
25
%
 
 
 
 
 
 
 
 
 
 
 
Residential mortgage-backed securities
 
$
17,740

 
Discounted cash flows
 
Cumulative loss rate
 
2%
 

 
 
 

 
   
 
Duration (years)
 
6.3 years
 

 
 
 

 
   
 
Discount rate/yield
 
3%
 

 
 
 
 
 
 
 
 
 
 
 
Commercial mortgage-backed securities
 
$
6,110

 
Discounted cash flows
 
Cumulative loss rate
 
7.3%
 

 
 
 

 
   
 
Duration (years)
 
0.2 years
 

 
 
 
 
 
 
Discount rate/yield
 
85%
 

 
 
 
 
Scenario analysis
 
Estimated recovery percentage
 
44%
 

 
 
 
 
 
 
 
 
 
 
 
 
 
Other asset-backed securities
 
$
42,563

 
Discounted cash flows
 
Cumulative loss rate
 
7
%
to
31%
 
16
%
 
 
 

 
   
 
Duration (years)
 
0.5 years

to
3 years
 
1.5 years
 
 
 

 
   
 
Discount rate/yield
 
7
%
to
15%
 
11
%
 
 
 
 
 
 
 
 
 
 
 
Loans and other receivables
 
$
112,574

 
Market approach
 
Price
 
$36
to
$100
 
$90
 
 
 

 
Scenario analysis
 
Estimated recovery percentage
 
87
%
to
104%
 
99
%
 
 
 
 
Discounted cash flows
 
Term based on the pay off (years)
 
0 months

to
0.1 years
 
0.1 years
 
 
 
 
 
 
 
 
 
 
 
Derivatives
 
$
13,826

 
 
 
 
 
 
 
 

Interest rate swaps
 
 
 
    Market approach
 
Basis points upfront
 
0

to
16
 
6

Unfunded commitments
 
 
 
 
 
Price
 
$88
 

Equity options
 
 
 
Volatility benchmarking
 
Volatility
 
45%
 

 
 
 
 
 
 
 
 
 
 
 
Investments at fair value
 
$
157,504

 
 
 
 
 
 
 
 

Private equity securities
 
 
 
Market approach
 
Price
 
$8
to
$250
 
$80
 
 
 
 
Scenario analysis
 
Discount rate/yield
 
19
%
to
21%
 
20
%
 
 
 
 
 
 
Revenue growth
 
0%
 

 
 
 
 
 
 
 
 
 
 
 
Investment in FXCM
 
$
59,120

 
 
 
 
 
 
 
 

Term loan
 
 
 
Discounted cash flows
 
Term based on the pay off (years)
 
0 months

to
1.2 years
 
1.2 years
 
 
 
 
 
 
 
 
 
 
 
Securities purchased under agreements to resell
 
$
25,000

 
Market approach
 
Spread to 6 month LIBOR
 
500
 

 
 
 
 
 
 
Duration (years)
 
1.5 years
 

 
 
 
 
 
 
 
 
 
 
 
Trading Liabilities
 
 
 
 
 
 
 
 
 
 
Corporate equity securities
 
$
4,487

 
Market approach
 
Transaction level
 
$1
 

 
 
 
 
 
 
 
 
 
 
 
Loans
 
$
9,463

 
Market approach
 
Price
 
$50
to
$100
 
$88
 
 
 
 
Scenario analysis
 
Estimated recovery percentage
 
1%
 

 
 
 
 
 
 
 
 
 
 
 
Derivatives
 
$
92,057

 
 
 
 
 
 
 
 

Equity options
 
 
 
Volatility benchmarking
 
Volatility
 
21
%
to
61%
 
43
%
Interest rate swaps
 
 
 
    Market approach
 
Basis points upfront
 
0

to
22
 
13

Cross currency swaps
 
 
 
 
 
Basis points upfront
 
2
 

Unfunded commitments
 
 
 
 
 
Price
 
$88
 

 
 
 
 
 
 
 
 
 
 
 
Long-term debt
 
$
480,069

 
 
 
 
 
 
 
 

Structured notes
 
 
 
    Market approach
 
Price
 
$84
to
$108
 
$96
 
 
 
 
 
 
Price
 
€74
to
€103
 
€91
November 30, 2018
Financial Instruments Owned
 
Fair Value
(in thousands)
 
Valuation
 Technique
 
Significant
Unobservable Input(s)
 
Input/Range
 
Weighted
Average
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate equity securities
 
$
43,644

 
 
 
 
 

 
 
Non-exchange traded securities
 
 

 
Market approach
 
Price
 
$1
to
$75
 
$12
 
 
 
 
 
 
Transaction level
 
$47
 

 
 


 
 
 
 
 

 
 
Corporate debt securities
 
$
9,484

 
Market approach
 
Estimated recovery percentage
 
46%
 

 
 
 
 
 
 
Transaction level
 
$80
 

 
 
 
 
 
 
 
 

 
 
CDOs and CLOs
 
$
36,105

 
Discounted cash flows
 
Constant prepayment rate
 
10
%
to
20%
 
18
%
 
 
 

 
   
 
Constant default rate
 
1
%
to
2%
 
2
%
 
 
 

 
   
 
Loss severity
 
25
%
to
30%
 
26
%
 
 
 

 
   
 
Discount rate/yield
 
11
%
to
16%
 
14
%
 
 
 
 
Scenario analysis
 
Estimated recovery percentage
 
2
%
to
41%
 
23
%
 
 
 
 

 

 

 


Residential mortgage-backed securities
 
$
19,603

 
Discounted cash flows
 
Cumulative loss rate
 
4%
 

 
 
 

 
   
 
Duration (years)
 
13 years
 

 
 
 

 
   
 
Discount rate/yield
 
3%
 

 
 
 
 
 
 
Loss severity
 
0%
 

 
 
 
 
    Market approach
 
Price
 
$100
 

 
 


 

 

 

 


Commercial mortgage-backed securities
 
$
9,444

 
Discounted cash flows
 
Cumulative loss rate
 
8
%
to
85%
 
45
%
 
 
 

 
   
 
Duration (years)
 
1 year

to
3 years
 
1 year
 
 
 
 

 
Discount rate/yield
 
2
%
to
15%
 
6
%
 
 
 
 
 
 
Loss severity
 
64%
 

 
 
 
 
Scenario analysis
 
Estimated recovery percentage
 
26%
 

 
 


 

 
Price
 
$49
 

 
 
 
 
 
 

 

 


Other asset-backed securities
 
$
53,175

 
Discounted cash flows
 
Cumulative loss rate
 
12
%
to
30%
 
22
%
 
 
 

 
   
 
Duration (years)
 
1 year

to
2 years
 
1 year
 
 
 

 
   
 
Discount rate/yield
 
6
%
to
12%
 
8
%
 
 
 
 
    Market approach
 
Price
 
$100
 

 
 


 

 
 
 

 
 
Loans and other receivables
 
$
46,078

 
Market approach
 
Price
 
$50
to
$100
 
$96
 
 
 

 
Scenario analysis
 
Estimated recovery percentage
 
13
%
to
117%
 
105
%
 
 
 
 
 
 
 
 
 
 
 
Derivatives
 
$
4,602

 
 
 
 
 
 
 
 

Total return swaps
 
 
 
    Market approach
 
Price
 
$97
 

 
 
 
 
 
 
 
 
 
 
 
Investments at fair value
 
$
368,231

 
 
 
 
 
 
 
 

Private equity securities
 
 
 
Market approach
 
Price
 
$3
to
$250
 
$108
 
 
 
 
 
 
Transaction level
 
$169
 

 
 
 
 
Scenario analysis
 
Discount rate/yield
 
20%
 

 
 
 
 
 
 
Revenue growth
 
0%
 

 
 


 
Contingent claims analysis
 
Volatility
 
25
%
to
35%
 
30
%
 
 
 
 

 
Duration (years)
 
4 years
 

 
 
 
 
 
 
 
 
 
 
 
Investment in FXCM
 
$
73,150

 
 
 
 
 
 
 
 

Term loan
 
 
 
Discounted cash flows
 
Term based on the pay off (years)
 
0 months

to
0.3 years
 
0.3 years
 
 

 
 
 
 
 
 
 
 
Trading Liabilities
 
 
 
 
 
 
 

 
 
Loans
 
$
6,376

 
Market approach
 
Price
 
$50
to
$101
 
$74
 
 
 
 

 

 

 


Derivatives
 
$
27,536

 
 
 
 
 
 
 
 

Equity options
 
 
 
Option model/default rate
 
   Default probability
 
0%
 

 
 
 
 
Volatility benchmarking
 
Volatility
 
39
%
to
62%
 
50
%
Interest rate swaps
 
 
 
    Market approach
 
Price
 
$20
 

Total return swaps
 
 
 
    Market approach
 
Price
 
$97
 

 
 
 
 
 
 
 
 
 
 
 
Long-term debt
 
$
200,745

 
 
 
 
 
 
 
 

Structured notes
 
 
 
    Market approach
 
Price
 
$78
to
$94
 
$86
 
 
 
 
 
 
Price
 
€68
to
€110
 
€96

Summary Of Gains (Losses) Due To Changes In Instrument Specific Credit Risk For Loans and Other Receivables And Loan Commitments Measured At Fair Value Under Fair Value Option
The following is a summary of our gains (losses) due to changes in instrument specific credit risk on loans, other receivables and debt instruments and gains (losses) due to other changes in fair value on long-term debt and short-term borrowings measured at fair value under the fair value option (in thousands):
 
Twelve Months Ended November 30, 2019
 
Eleven Months Ended November 30, 2018
 
Twelve Months Ended December 31, 2017
Trading Assets:
 
 
 
 
 
Loans and other receivables
$
(2,072
)
 
$
(3,856
)
 
$
22,088

 
 
 
 
 
 
Trading Liabilities:
 

 
 

 
 

Loans
656

 
(46
)
 

Loan commitments
(1,089
)
 
(739
)
 
230

 
 
 
 
 
 
Long-term debt:
 
 
 
 
 
Changes in instrument specific credit risk (1)
(20,332
)
 
38,064

 
(34,609
)
Other changes in fair value (2)
(25,144
)
 
48,748

 
47,291

 
 
 
 
 
 
Short-term borrowings:
 
 
 
 
 
Changes in instrument specific credit risk (1)
114

 

 

Other changes in fair value (2)
(863
)
 

 
(681
)
(1)
Changes in instrument specific credit risk related to structured notes are included in the Consolidated Statements of Comprehensive Income (Loss), net of taxes.
(2)
Other changes in fair value are included within Principal transactions revenues in the Consolidated Statements of Operations.

Summary Of Amount By Which Contractual Principal Exceeds Fair Value For Loans And Other Receivables Measured At Fair Value Under Fair Value Option
The following is a summary of the amount by which contractual principal exceeds fair value for loans and other receivables, long-term debt and short-term borrowings measured at fair value under the fair value option (in thousands):
 
November 30, 2019
 
November 30, 2018
Trading Assets:
 
 
 
Loans and other receivables (1)
$
1,546,516

 
$
961,554

Loans and other receivables on nonaccrual status and/or 90 days or greater
  past due (1) (2)
197,215

 
158,392

Long-term debt and short-term borrowings
74,408

 
114,669


(1)
Interest income is recognized separately from other changes in fair value and is included in Interest income in the Consolidated Statements of Operations.
(2)
Amounts include loans and other receivables 90 days or greater past due by which contractual principal exceeds fair value of $22.2 million and $20.5 million at November 30, 2019 and 2018, respectively.